COMPANY

icometrix

Keywords: neurology Multiple Sclerosis Radiologically Isolated Syndrome Clinically Isolated Syndrome NMO Spectrum Disorder Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Profile checked Oct 10, 2026

3Trials (company is sponsor)

Timeline

Oct 9, 2025 Trial start Not phased (device or behavioral study): Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study source ↗
Mar 1, 2024 Trial start —: Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study. source ↗
Jan 7, 2023 Trial start —: CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis source ↗

Upcoming milestones

2027-04 (ESTIMATED) · · Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study. · NCT06280755
Aug 31, 2028 (ESTIMATED) · Not phased · Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study · NCT07032246

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 3

Record	Title	Phase	Status	Start	Primary completion
NCT06280755	Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.	Not listed	Recruiting	Mar 1, 2024	2027-04 (estimated)
NCT07032246	Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study	Not phased (device or behavioral study)	Enrolling by invitation	Oct 9, 2025	Aug 31, 2028 (estimated)
NCT05671055	CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis	Not listed	Completed	Jan 7, 2023	Dec 6, 2023 (actual)

Connect

See your connections at icometrix on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12